FACTORS INVOLVED IN THE DEPRESSION OF HEPATIC MIXED-FUNCTION OXIDASE DURING INFECTIONS WITH LISTERIA-MONOCYTOGENES

被引:13
作者
AZRI, S
RENTON, KW
机构
[1] Department of Pharmacology, Dalhousie University, Halifax
来源
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1991年 / 13卷 / 2-3期
基金
英国医学研究理事会;
关键词
D O I
10.1016/0192-0561(91)90099-S
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A number of infections are capable of depressing the capacity of the liver to metabolize drugs. We have studied a number of factors which could be involved in the depression of cytochrome P-450 and related drug biotransformation enzymes during infections with Listeria monocytogenes. During the course of the infection, durg metabolism and heme content of hepatic microsomes were depressed but heme oxygenase was elevated. A free radical scavenger alpha-tocopherol did not prevent the loss and xanthine oxidase activities did not correlate with the time course of the loss. Infections in susceptible (balb/c) mice produced a larger loss in drug metabolism than in resistant (C57BL/6) mice, and an avirulent strain of the bacteria was without effect. A preparation of hemolysin isolated from Listeria monocytogenes produced a dose-dependent loss of cytochrome P-450 in isolated hepatocytes. These experiments indicate that the loss of drug metabolism during Listeria infections is most likely due to hemolysin released by the bacteria.
引用
收藏
页码:197 / 204
页数:8
相关论文
共 43 条
[1]  
AZRI S, 1987, J PHARMACOL EXP THER, V243, P1089
[2]  
BORTOLUSSI R, 1984, CLIN INVEST MED, V7, P273
[3]  
CHANG KC, 1978, LANCET, V1, P1132
[4]   RESISTANCE AND SUSCEPTIBILITY OF MICE TO BACTERIAL-INFECTION - COURSE OF LISTERIOSIS IN RESISTANT OR SUSCEPTIBLE MICE [J].
CHEERS, C ;
MCKENZIE, IFC ;
PAVLOV, H ;
WAID, C ;
YORK, J .
INFECTION AND IMMUNITY, 1978, 19 (03) :763-770
[5]  
COCHIN J, 1950, J PHARMACOL EXP THER, V99, P171
[7]   INDUCTION OF XANTHINE-OXIDASE AND DEPRESSION OF CYTOCHROME-P-450 BY INTERFERON INDUCERS - GENETIC DIFFERENCE IN THE RESPONSES OF MICE [J].
DELORIA, L ;
ABBOTT, V ;
GOODERHAM, N ;
MANNERING, GJ .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1985, 131 (01) :109-114
[8]  
El Defrawy El Masry S., 1974, DRUG METAB DISPOS, V2, P279
[9]  
Ernster L., 1967, METHODS ENZYMOL, V10, P574, DOI [10.1016/0076-6879(67)10099-2, DOI 10.1016/0076-6879(67)10099-2]
[10]   DECREASE OF THE INVITRO DRUG-METABOLIZING ACTIVITY OF THE HEPATIC MIXED-FUNCTION OXIDASE SYSTEM IN RATS INFECTED EXPERIMENTALLY WITH FASCIOLA-HEPATICA - PHARMACOLOGICAL IMPLICATIONS [J].
FACINO, RM ;
CARINI, M ;
BERTULETTI, R ;
GENCHI, C ;
MALCHIODI, A .
PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1981, 13 (08) :731-742